Optical Coherence Tomography (OCT)

Optical coherence tomography (OCT) is an catheter-based intravascular imaging technology that uses low-coherence light interferometry, using near-infrared light, to capture high-resolution 2-D and 3-D image reconstructions of coronary arteries. It has a lower level of tissue penetration than intravascular ultrasound (IVUS), but offers much higher resolution images of the tissues. It is used to determine the nature and extent of the atheroscleratic disease in the vessel wall, to assess in-stent restenosis and aid catheter procedure navigation in the cath lab.

Abbott OCT intravascular imaging explained.
News | Optical Coherence Tomography (OCT) | June 26, 2020
June 26, 2020 — Abbott announced new data from the company's LightLab Initiative that showed optical coherence...
An OCT intracoronary image showing instent restenosis. The white spots in the vessel wall casting shadows are the stent struts. OCT image data might be used in the future to assess FFR to determine the severity of lesions and determine if they need to be stented.

An OCT intracoronary image showing instent restenosis. The white spots in the vessel wall casting shadows are the stent struts. OCT image data might be used in the future to assess FFR to determine the severity of lesions and determine if they need to be stented.

News | FFR Technologies | May 15, 2020
May 15, 2020 – A late-breaking study aimed to evaluate whether optical coherence tomography (OCT) can predict...
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and...
First U.S. Patients Treated With Second-Generation Pantheris Atherectomy Device
News | Atherectomy Devices | July 18, 2018
July 18, 2018 — Avinger Inc. announced in June that several physicians have successfully treated over 40 patients for...
OCT Reveals Excellent Healing Profile for Complex CAD Patients With Resolute Onyx DES
News | Stents Drug Eluting | May 29, 2018
May 29, 2018 – Investigators recently unveiled clinical data from the independently run Onyx 1-Month OCT Study showing...
Avinger Receives FDA Clearance of Next-Generation Pantheris Device
Technology | Atherectomy Devices | May 24, 2018
May 24, 2018 — Avinger Inc. announced that the company received 510(k) clearance from the U.S. Food & Drug...
Recent Acquisitions Eroding Prices in Billion Dollar European Interventional Cardiology cath lab Market.
Feature | Cath Lab | May 07, 2018 | Simon Trinh and Jeffrey Wong
The European interventional cardiology market is currently valued at nearly $1.4 billion. This is a mature market that...
Technology | Intravascular Imaging | May 02, 2018
May 2, 2018 — Conavi Medical Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for...
Abbott Initiates ILUMIEN IV Trial
News | Optical Coherence Tomography (OCT) | April 11, 2018
April 11, 2018 — Abbott today announced the initiation of a clinical trial evaluating long-term outcomes of patients...
Avinger Receives CE Mark for In-Stent Restenosis Indication With Pantheris Image-Guided Atherectomy
Technology | Atherectomy Devices | September 29, 2017
September 29, 2017 — Avinger Inc. recently announced Conformité Européenne (CE) Marking approval for treating in-stent...
Avinger, VISION Study, two-year outcomes, LINC, Lumivascular technology, Pantheris, OCT-guided atherectomy
News | Atherectomy Devices | February 03, 2017
February 3, 2017 — Avinger Inc. recently announced positive two-year clinical data from the pivotal VISION study of the...
Avinger, Lightbox L250 imaging console, upgrade, Lumivascular platform, OCT, optical coherence tomography
Technology | Intravascular Imaging | January 11, 2017
January 11, 2017 — Avinger Inc. recently announced the U.S. launch of an enhanced version of the company’s Lightbox...
Pantheris, OCT, Avinger, Lightbox L250
Technology | Atherectomy Devices | December 23, 2016
December 23, 2016 — The U.S. Food and Drug Administration (FDA) granted a new 510(k) clearance for Avinger’s Lightbox...
Videos | TCT | November 18, 2016
DAIC Editor Dave Fornell takes a video tour of some of the most innovative new interventional cardiology technologies...
OCT stent strut coverage

OCT imaging showing neointimal tissue coverage of metallic stent struts.

News | Stents | November 07, 2016
November 7, 2016 – Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OCT...